MedTrace Logo

High Flow Nasal Cannula Therapy in Bronchiolitis : Early vs Rescue

NCT03095495 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2024-09-19

No results posted yet for this study

Summary

The enrolled RSV-bronchiolitis patients will be randomized into two arms , the early HHHFNC group and the standard therapy group with rescue HHHFNC to study the efficacy of this treatment.

Conditions

  • Bronchiolitis
  • Respiratory Syncytial Virus (RSV)

Interventions

DEVICE

Heated Humidified High Flow Nasal Cannula

HHHFNC therapy is a simple to use system that delivers warm and moist air/oxygen mixture at high flow rates that generate positive airway pressure

DEVICE

Standard Therapy (Low Flow Nasal Cannula)

will be used only if the patient needs oxygenation and Rescue HHHFNC will be used if the patient needs PICU

Sponsors & Collaborators

  • Sidra Medicine

    collaborator OTHER

  • Hamad Medical Corporation

    lead INDUSTRY

Principal Investigators

  • Khalid Alansari, MD · Hamad Medical Corporation

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Max Age
3 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-14
Primary Completion
2024-05-28
Completion
2024-05-28

Countries

  • Qatar

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03095495 on ClinicalTrials.gov